Cardona-Hernández M?, González-González M, Jurado-Santa CF, Romero-Guzmán AK

Language: Spanish
References: 18
Page: 34-38
PDF size: 262.66 Kb.

ABSTRACT

Deep nodular tuberculosis is considered a tuberculide. Its diagnosis is based on the clinical characteristics, a positive tuberculin test, evidence of M. tuberculosis in another body site and, at the histopathological level, the presence of granulomatous lobular panniculitis. In this article we report the case of a 45-year-old woman with deep nodular tuberculosis, who initially improved with the administration of conventional antifimic therapy, with recurrence of the condition at the end of treatment. A bibliographic review is carried out in this regard.

REFERENCES

1. van Zyl L, du Plessis J, Viljoen J. Cutaneous tuberculosis overview and current treatment regimens. Tuberculosis (Edinb). 2015; 95: 629-638.

2. Melsew YA, Doan TN, Gambhir M, Cheng AC, McBryde E, Trauer JM. Risk factors for infectiousness of patients with tuberculosis: a systematic review and meta-analysis. Epidemiol Infect. 2018; 146: 345-353.

3. Suárez Castañón C, Pérez Méndez C, Alvarez Cuesta CC, Corrales Canel B, Blanco Costa MI. Erythema induratum of Bazin associated to Mycobacterium tuberculosis infection. Arch Argent Pediatr. 2012; 110: e43-e46.

4. Rodríguez O. Tuberculosis cutánea. Rev Fac Med UNAM. 2003; 46: 157-161.

5. Bravo F, Gotuzzo E. Cutaneous tuberculosis. Clin Dermatol. 2007; 25: 173-180.

6. Calonje JE, Brenn T, Lazar A, Billings S. McKee's pathology of the skin. 4th edition. New York: Elsevier; 2012. pp. 346-349.

7. Chakrabortty R, Rahman MA, Ferdousi KR, Paul BK. Cutaneous tuberculosis: an update. Mymensingh Med J. 2016; 25: 385-391.

8. Tirado-Sánchez A, Bonifaz A. Cutaneous tuberculosis: a review of the current literature. Curr Trop Med Rep. 2018; 5: 67-76.

9. Maldonado-Bernal C, Ramos-Garibay A, Rios-Sarabia N, Serrano H, Carrera M, Navarrete-Franco G et al. Nested polymerase chain reaction and cutaneous tuberculosis. Am J Dermatopathol. 2019; 41: 428-435.

10. Secretaría de Salud. Programa de acción específico. Tuberculosis. 2013-2018. México: 2018. pp. 11-42.

11. Nirmala C, Nagarajappa N. Erythema induratum. A type of cutaneous tuberculosis. Indian J Tuberc. 2010; 57: 160-164.

12. Chen Q, Chen W, Hao F. Cutaneous tuberculosis: a great imitator. Clin Dermatol. 2019; 37: 192-199.

13. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica. Manual de recomendações para o controle da tuberculose no Brasil. [Ministry of Health. Secretary of Health Surveillance. Department of Epidemiological Surveillance. Guide: recommendations for tuberculosis control in Brazil] Brasília: Ministério da Saúde; 2011. p. 284.

14. Centers for Disease Control and Prevention. Tuberculosis: laboratory information. [Accessed on June 16, 2016] Available in: http://www.cdc.gov/tb/topic/laboratory/

15. Centers for Disease Control and Prevention. Reference Laboratory Division of TB Elimination Laboratory User Guide for U.S. Public Health Laboratories: molecular detection of drug resistance (MDDR) in Mycobacterium tuberculosis complex by DNA sequencing (Version 2.0), June 2012. CDC, Atlanta, GA 2012. [Accessed on June 16, 2016] Available in: http://www.cdc.gov/tb/topic/laboratory/mddrusersguide.pdf

16. Marx FM, Dunbar R, Enarson DA, Williams BG, Warren RM, van der Spuy GD et al. The temporal dynamics of relapse and reinfection tuberculosis after successful treatment: a retrospective cohort study. Clin Infect Dis. 2014; 58: 1676-1683.

17. Secretaría de Salud. Guía para la atención de personas con tuberculosis resistente a fármacos. Disponible en: http://www.cenaprece.salud.gob.mx/programas/interior/micobacteriosis/descargas/pdf/guia_tb_mfr_ok.pdf

18. World Health Organization. Using the Xpert MTB/RIF assay to detect pulmonary and extrapulmonary tuberculosis and rifampicin resistance in adults and children: expert group meeting report: 2013. Geneva: World Health Organization.